Sanofi (LTS:0O59) FFO


LTS:0O59 Sanofi SA LTS:0O59
77 GF Score
Price €75.99
GF Value €107.13
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sanofi FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0O59
77GF Score
Sanofi SA LTS:0O59
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sanofi (LTS:0O59) Overvalued in 2026?

Based on GuruFocus' analysis, Sanofi stock appears to be undervalued. The current stock price of €75.99 is trading 29.1% below its estimated GF Value™ of €107.13. GuruFocus considers Sanofi to be Modestly Undervalued.

Key valuation signals for LTS:0O59:

  • FFO:
  • GF Value™: €107.13 vs. price of €75.99 (29.1% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the LTS:0O59 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sanofi Business Description

Address 46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
77GF Score

Get the complete analysis for LTS:0O59

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€75.99
Price
€107.13
GF Value